Hospital
Baptist Health Care, INC.
Baptist Health Care, INC. was paid $1.30M by Medicaid between Jan 2018 and Jun 2024, across 94 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 19% of everything it billed.
33Billing provider infoBAPTIST HEALTH CARE, INC.
GULF BREEZE, FL 32561
GULF BREEZE, FL 32561
33aNPI1972664530assigned 12/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.30M
24GClaims91,594
24DCodes billed94
24AFirst – last monthJan 2018 – Jun 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#126 of 163
Median peer was paid$4.77M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,615 | $84K | |
| 2019 | 20,301 | $363K | |
| 2020 | 17,589 | $213K | |
| 2021 | 19,110 | $238K | |
| 2022 | 18,644 | $300K | |
| 2023 | 5,261 | $94K | |
| 2024incomplete | 74 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 19% | 3,943 | 1,098 | $243K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 4,608 | 3,950 | $227K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 4,473 | 3,686 | $144K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.9% | 1,844 | 1,598 | $103K |
| 80053 | Comprehensive metabolic panel | 6.9% | 7,330 | 5,705 | $90K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.4% | 540 | 467 | $56K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.0% | 1,155 | 872 | $52K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 881 | 696 | $51K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.5% | 1,177 | 935 | $46K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.1% | 2,682 | 717 | $27K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 4,205 | 3,099 | $19K |
| 84703 | 1.3% | 2,065 | 1,761 | $17K |
82 more codes
| 73630 | 1.0% | 624 | $13K | |
| 73610 | <1% | 413 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 483 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,557 | $11K |
| 97161 | <1% | 117 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,103 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,269 | $9K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,707 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,092 | $7K |
| 81001 | <1% | 3,520 | $7K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 44 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,848 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 913 | $6K |
| 87081 | <1% | 119 | $6K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 773 | $5K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,284 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 46 | $5K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 42 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 266 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,359 | $4K |
| 99001 | <1% | 424 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,025 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 896 | $4K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,014 | $4K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 30 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 850 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,203 | $3K |
| 96376 | <1% | 382 | $3K | |
| 97016 | <1% | 492 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,883 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 319 | $3K |
| J3490 | Unclassified drugs | <1% | 1,021 | $2K |
| 83690 | <1% | 2,398 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 491 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 121 | $2K |
| 97162 | <1% | 27 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,303 | $2K |
| 73030 | <1% | 93 | $2K | |
| 73110 | <1% | 33 | $1K | |
| 83735 | <1% | 1,916 | $1K | |
| 84484 | <1% | 1,590 | $1K | |
| 82550 | <1% | 1,553 | $1K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 268 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,249 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 694 | $1K |
| 73562 | <1% | 60 | $1K | |
| 73130 | <1% | 29 | $1K | |
| 80061 | Lipid panel | <1% | 991 | $991.73 |
| 80305 | <1% | 257 | $990.38 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,306 | $902.44 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,085 | $850.31 |
| 81003 | <1% | 643 | $808.80 | |
| 73502 | <1% | 48 | $629.52 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 16 | $549.33 |
| 84439 | <1% | 302 | $379.70 | |
| 85027 | <1% | 196 | $337.01 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 561 | $305.27 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 172 | $242.13 |
| 72100 | <1% | 14 | $208.34 | |
| 73564 | <1% | 19 | $188.20 | |
| 87077 | <1% | 49 | $162.57 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 112 | $137.70 |
| 87186 | <1% | 29 | $135.81 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $94.85 |
| 82607 | <1% | 159 | $89.47 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 31 | $81.67 |
| 85651 | <1% | 29 | $73.65 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 74 | $73.38 |
| 82746 | <1% | 55 | $13.51 | |
| 85610 | <1% | 29 | $7.02 | |
| 82150 | <1% | 13 | $5.37 | |
| 82553 | <1% | 125 | $4.11 | |
| 93041 | <1% | 49 | $2.06 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 164 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 14 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 14 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 37 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 18 | $0.00 |
| 99152 | 0% | 63 | $0.00 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 32 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUDNALL, ASHLEE (DIRECTOR OF REVENUE CYCLE OPERATION)
| Provider | Location | Paid |
|---|---|---|
| Baptist Health Care, INC | Pensacola, FL | $18.46M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.